antineoplastisch middel
Monoclonal IgG
Programmed cell death protein 1 inhibitor
|
|
|
Tislelizumab (substance)
Tislelizumab
Id
1363351004
Status
Primitive
Has disposition
geprogrammeerde celdood-1-receptorremmer
